rs398124177
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004586.3(RPS6KA3):c.632-1G>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004586.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Coffin-Lowry syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen, G2P
- intellectual disability, X-linked 19Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- symptomatic form of Coffin-Lowry syndrome in female carriersInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RPS6KA3 | NM_004586.3 | c.632-1G>C | splice_acceptor_variant, intron_variant | Intron 8 of 21 | ENST00000379565.9 | NP_004577.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RPS6KA3 | ENST00000379565.9 | c.632-1G>C | splice_acceptor_variant, intron_variant | Intron 8 of 21 | 1 | NM_004586.3 | ENSP00000368884.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Coffin-Lowry syndrome Pathogenic:1
Inborn genetic diseases Pathogenic:1
The c.632-1G>C intronic alteration results from of a G to C substitution one nucleotide before coding exon 9 of the RPS6KA3 gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD), the RPS6KA3 c.632-1G>C alteration was not observed, with coverage at this position. An alteration affecting the same nucleotide, c.632-1G>T, was reported in a patient with clinical features suggestive of Coffin-Lowry syndrome (Jacquot, 1998). The c.632-1G nucleotide is conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. Based on the available evidence, this alteration is classified as likely pathogenic.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at